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Abstract: The relationships between cancer incidence rates and the age of patients at cancer diagnosis are a quantitative basis for 
modeling age distributions of cancer. The obtained model parameters are needed to build rigorous statistical and biological models 
of cancer development. In this work, a new mathematical model, called the Generalized Beta (GB) model is proposed. Confidence 
intervals for parameters of this model are derived from a regression analysis. The GB model was used to approximate the incidence rates 
of the first primary, microscopically confirmed cases of pancreatic cancer (PC) and kidney cancer (KC) that served as a test bed for the 
proposed approach. The use of the GB model allowed us to determine analytical functions that provide an excellent fit for the observed 
incidence rates for PC and KC in white males and females. We make the case that the cancer incidence rates can be characterized by a 
unique set of model parameters (such as an overall cancer rate, and the degree of increase and decrease of cancer incidence rates). Our 
results suggest that the proposed approach significantly expands possibilities and improves the performance of existing mathematical 
models and will be very useful for modeling carcinogenic processes characteristic of cancers. To better understand the biological 
plausibility behind the aforementioned model parameters, detailed molecular, cellular, and tissue-specific mechanisms underlying the 
development of each type of cancer require further investigation. The model parameters that can be assessed by the proposed approach 
will complement and challenge future biomedical and epidemiological studies.
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Introduction
The  number  of  newly  diagnosed  primary  cancers 
at  particular  organ  sites  occurring  in  a  specified 
population during a given time period (for instance, 
one year or five years), is called the cancer incidence 
rate. The rate of cancer incidence for a specific age 
group during this time period is called the age-specific 
incidence rate. Usually, the age-specific incidence rates 
are presented as the number of cancers per 100,000 
persons in a specified age group. The sequence of age-
specific incidence rates for all specified age groups is 
referred to as the age distribution of a given cancer. 
A mathematical modeling of the age distribution of 
cancer results in a simple analytical function, I(t), that 
can approximate observed values of cancer incidence 
rates and provides parameters of this function. The 
obtained  model  parameters  can  be  further  used  to 
build rigorous statistical and/or biological models of 
cancer development.
Development  of  mathematical  models  of  age-
specific  cancer  incidence  rates  began  more  than 
55 years ago. Analyzing cancer mortality rates in the 
UK, Nordling,1 as well as Armitage and Doll,2 noticed 
the  existence  of  two  age  periods  in  which  cancer 
mortality  manifests  differently.  In  the  initial  age 
period, a number of cancer mortalities per population 
at a given age is equal or close to 0. For the majority 
of adult onset cancers, this period is extended between 
birth and an age when the cancer presentation begins 
growing  exponentially.  In  the  second  age  period, 
the cancer mortality per population at a given age is 
exponentially growing with aging.
The  first  mathematical  model  of  cancer 
presentation in aging was proposed by Armitage and 
Doll (the AD model).2 This model can be presented 
in the following way:
	 I(t) = ct	 k	- 1  (1)
where I(t) is the modeled cancer incidence rate at 
age t; c is a parameter characterizing overall cancer 
susceptibility in a population at cancer risk, and k is 
the number of stages of cancer development. This 
model  describes  the  relationship  between  cancer 
incidence rates and aging, when cancer development 
is in the exponential growth phase.
Cook,  Doll  and  Fellingham  found  a  single 
increasing linear trend for the logarithm of many cancer 
incidences plotted as a function of the logarithm of 
age at diagnosis,3 presumably reflecting accumulated 
lifetime carcinogenic risks and/or exposures. This led 
to conclusions that: (i) the number of stages of cancer 
presentation (parameter k) can vary between different 
cancer  tissues,  but  is  constant  for  a  given  cancer 
organ site, and (ii) the overall cancer susceptibility 
(parameter c) may be dependent on the geographical 
location (country of residency) of the population at 
cancer risk.
Extrapolation of the AD model to ages older than 
70 years (up to which observed data was considered 
reliable at the time the AD model was proposed) can 
lead to a statement that if	a	person	lives	long	enough,	
sooner	or	later	he/she	will	get	cancer. However, Cook, 
Doll  and  Fellingham  considered  the  possibility  of 
flattening incidence rates of cancer in ages above 60.3 
For  this  purpose,  they  assumed  that  only  a  very 
limited and fixed fraction of the whole population 
is susceptible to a particular type of cancer. In this 
case, the cancer-sensitive fraction of a population will 
decrease with increasing age that, in turn, will cause a 
flattening of the cancer incidence rates at old ages.
In the second half of the 20th century, the quality of 
the collected cancer incidence rate data has improved 
markedly.  Thanks  to  the  implementation  of  the 
Surveillance, Epidemiology, and End Results (SEER) 
program, a lot of reliable data on the cancer incidence 
rates for specific organ sites at different ages (including 
the  oldest  ones)  were  collected.4  Using  the  SEER 
database, Pompei and Wilson showed that patterns of 
the age-specific incidence rate for the fixed time period 
(2000–2004) for most common adult cancers have a 
turnover point (near the age of 80),5 after which these 
patterns have a tendency to fall and may reach a value 
of 0 as age increases toward the end of the human 
life span. This observation encouraged Pompei and 
Wilson to extrapolate the AD model beyond the age 
of 70 to the life span by adding an additional term to 
Equation 1, resulting in:
	 I(t) = (at)k	- 1(1 - bt)  (2)
where  the  a  parameter  is  a  constant  for  limiting 
stage transitions; k reflects the number of these rate-
limiting  (slow)  stages  required  to  initiate  cancer; 
and b is a parameter, whose meaning can be easily 
described by its reciprocal value, 1/b, that presents an 
age at which I(t) becomes 0. Equation 2 is a special 
form of the Beta function.Modeling of cancer incidence rates in aging
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Recently,  Harding,  Pompei,  Lee  and  Wilson 
modified Equation 2 to:
	 I(t) = ct	 k	- 1(1 - bt)  (3)
where  the  c  parameter  characterizes  a  combined 
rate  constant  for  limiting  stage  transitions. Values 
of the c, k and b parameters can be determined by 
best-fitting the age-specific incidence rates collected 
in the SEER database.6 Below, we will refer to this 
model as the Pompei and Wilson (PW) model.
By adjusting c, k and b of Equation 3, Harding and 
coauthors performed curve fitting for the age-specific 
cancer incidence rates for 20 major organ sites listed 
in SEER for males and 21 major organ sites listed for 
females.6 A satisfactory data fitting was shown for 
many of the examined cancer sites. It was also shown 
that  the  age-specific  incidence  rate  distributions 
demonstrated  a  common  shape.  In  36  of  the 
41 considered cancer sites (for males and females), 
this common shape was characterized by the location 
of the corresponding distribution peaks (the incidence 
rate turnover near the age of 80), and relatively small 
(10%)  variability  of  1/b  (near  age  of  100).  The 
k  values  varied  between  2.4  and  10.6.  Very  large 
variations (more than five orders of magnitude) were 
found for the c values.
In all the aforementioned works, the modeling of 
age  distribution  of  cancer  was  performed  without 
considering time period and cohort effects. However, 
ignorance  of  these  effects  could  seriously  distort 
cancer  presentation  in  aging.7–10  Recently,  Meza, 
Jihyoun,  Moolgavkar,  and  Luebeck  carried  out  an 
adjustment  of  the  observed  age-specific  incidence 
rates of colorectal and pancreatic cancers for birth 
cohort and time period effects and did not observe a 
turnover point at old ages.11 These authors proposed to 
present distribution of the adjusted cancer incidence 
rates by a composition of two analytical functions: 
(i) a power (or exponential) function that up to the 
age  of  approximately  60  years  remains  the  same 
as in the AD model; and (ii) a linear function, after 
the ages of 60+. Thus, Meza and coauthors not only 
rejected the existence of the turnover points of the 
age distribution of cancer at old ages (at least in the 
cases of the colorectal and pancreatic cancers) but 
also stated that for the ages beyond 60 years the linear 
function  approximates  the  adjusted  observational 
data better than other functions used before.
In addition to ignorance of the time period and 
cohort effects, there are other potential problems in 
the  utilization  of  mathematical  models  for  studies 
of the age distribution of cancer. Most models use 
raw  incidence  rate  data  without  omitting  cases 
corresponding  to  second  primary  or  secondary 
tumors, and do not omit cases which have not been 
microscopically confirmed. Also, these models do not 
provide means to calculate confidence intervals for 
the determined model parameters.12
The  present  work  is  aimed  at  overcoming  the 
aforementioned shortcomings in the modeling of age 
distribution in cancer.
Materials and Methods
Data preparation and filtration
To build mathematical models for age distribution in 
PC and KC, we used data from the SEER 9 registries 
that contain cancer data collected in the following 
nine locations: Atlanta, Connecticut, Detroit, Hawaii, 
Iowa, New Mexico, San Francisco-Oakland, Seattle-
Puget Sound, and Utah. In the SEER database, each 
case record contains information on whether this is 
the first primary malignant case and whether the case 
is histopathologically confirmed. Limiting inclusion 
to cases where the patient was of known race and 
whose case indicated a first primary, microscopically 
confirmed tumor is considered to be a filtered data, 
and data where this filtering was not performed is 
considered  to  be  a  raw  data.  For  age  distribution 
modeling, we used the filtered data, which are expected 
to be more reliable than raw data. We utilized the 
incidence rate data expressed per 100,000 persons to 
the nearest 0.0001 decimal place and age-adjusted by 
the direct method to the 2000 United States standard 
population.13
We used SEER 9 data collected during the 20-year 
time period between 1985 and 2004. To smooth out 
random fluctuations, the data were combined in four 
five-year  cross-sectional  time  periods:  1985–1989; 
1990–1994;  1995–1999;  and  2000–2004.  For  PC 
and  KC,  the  gender-specific  incidence  rates  were 
grouped  into  18  five-year  age  groups:  17  groups, 
ranging from 0 to 84 years old, and the 18th group 
that included all cases for ages 85 or over. For each of 
these intervals, i, the corresponding I(ti) and standard 
errors (SEi) were obtained by processing the SEER 
data according to SEER’s rate algorithms.14 For each Mdzinarishvili et al
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age interval, the values of the coefficient of variance 
were also determined as: CV SE I t i i i = ( ).
Birth cohort and time period adjustments
We assumed that each observed incidence rate, Iij(ti), 
can be estimated as a product of the corresponding 
coefficient of time period effect, vj, coefficient of 
cohort  effect,  ul,  and  theoretical  incidence  rate 
(or  the  hazard  function  depending  only  on  age), 
h(ti), i.e.
	 Iij(ti) = vjulh(ti)  (4)
where i, j, and l are indexes of the age, time period 
and birth cohorts, correspondingly; and t	=	ti is the 
midpoint of the corresponding age group.11,15 Indices 
i and j determine index l (see below). The birth cohort 
and time period adjustments performed in this work 
can be easily described by the use of Table 1 and Table 2.
Table  1  schematically  presents  the  incidence 
rate  of  data  collected  in  1985–1989,  1990–1994, 
1995–1999,  and  2000–2004.  In  this  Table,  the 
incidence rates of the same cohorts are located along 
diagonals. We used data for the age groups over age 
30 (index i	= 7, …, 18), because the incidence rates 
for these age groups are statistically different from 
0. We also limited our analysis by nine birth cohorts 
(index l	= 1, …, 9). The first cohort includes patients 
that were born in years of 1915–1919, while the ninth 
cohort is formed from patients born in 1955–1959. In 
Table 1, each of these nine birth cohorts are marked 
by  an  arrow  linking  the  diagonal  cells,  in  which 
the cancer incidence rates observed for this group 
in each time period are presented.
Table  2  schematically  presents  the  observed 
incidence rates as a product of the hazard function, 
h(ti),  and  the  corresponding  time  period  and  birth 
cohort  coefficients,  v  and  u.  As  can  be  seen  on 
the  corresponding  diagonals  in  Table  2,  there  are 
four approximations of the observations related to the 
first cohort: v1u1h(t15), v2u1h(t16), v3u1h(t17), v4u1h(t18). 
Analogously, there are four approximations for each 
of the other eight cohorts. (Note that in this Table 
we  did  not  provide  data  corresponding  to  other 
Table 1. Presentation of the observed age-specific incidence rates for nine birth cohort groups during four time periods.
period of observation
Age group 1985–89 1990–94 1995–99 2000–04 Birth cohort
Index, i Mid point, ti j = 1 j = 2 j = 3 j = 4 Index, l Years
1 2.5
⋅⋅⋅ ⋅⋅⋅
7 32.5 I7,1(t7) I7,2(t7) I7,3(t7) I7,4(t7)
8 37.5 I8,1(t8) I8,2(t8) I8,3(t8) I8,4(t8)
9 42.5 I9,1(t9) I9,2(t9) I9,3(t9) I9,4(t9)
10 47.5 I10,1(t10) I10,2(t10) I10,3(t10) I10,4(t10) 9 1955–59
11 52.5 I11,1(t11) I11,2(t11) I11,3(t11) I11,4(t11) 8 1950–54
12 57.5 I12,1(t12) I12,2(t12) I12,3(t12) I12,4(t12) 7 1945–49
13 62.5 I13,1(t13) I13,2(t13) I13,3(t13) I13,4(t13) 6 1940–44
14 67.5 I14,1(t14) I14,2(t14) I14,3(t14) I14,4(t14) 5 1935–39
15 72.5 I15,1(t15) I15,2(t15) I15,3(t15) I15,4(t15) 4 1930–34
16 77.5 I16,1(t16) I16,2(t16) I16,3(t16) I16,4(t16) 3 1925–29
17 82.5 I17,1(t17) I17,2(t17) I17,3(t17) I17,4(t17) 2 1920–24
18 87.5+ I18,1(t18) I18,2(t18) I18,3(t18) I18,4(t18) 1 1915–19Modeling of cancer incidence rates in aging
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cohorts:  the  cells  that  should  be  assigned  for  the 
1900–04, 1905–09, 1910–14, 1960–64, 1965–69, and 
1970–74 birth cohorts are empty. For these cohorts, 
the numbers of observations are less than four and 
their corresponding coefficients, u, should be treated 
with  a  lower  weight  than  ones  for  the  considered 
groups. Therefore, we used the most homogeneous 
and reliable data.)
From Table 2, the relationship between indexes 
i, j, and l can be presented as: l	=	j	-	i	+ 15. Now, 
assuming the absence of the cohort effect (u = 1) and 
using Equation 4 and Table 2, we can estimate the 
ratios of the coefficients of the time period effect in 
the following way:
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From this system of three Equations we can obtain 
thee unknowns, v2, v3, and v4, by setting v1 = 1.
Analogously,  assuming  the  absence  of  the  time 
effect (v = 1), we can obtain estimates of the ratios of 
the coefficients of the cohort effect:
time period effect, v, using the system of equations 
(Equation 5). Then, we fixed the obtained time period 
coefficients and corrected the observed incidence rates 
by  dividing  them  by  the  coefficients  presented  in 
Equation 4. Continuing, we estimated the coefficients 
of the cohort effect, u, from the system of equations 
(Equation  6),  in  which  the  time  effect-corrected 
incidence rates were used. Assuming v = 1 in Equation 4 
and using the estimated cohort effect coefficients u, 
the incidence rates can be corrected one more time.
This adjusting procedure aims to correct possible 
systematic errors in the observed age-specific incidence 
rates, Iij. After such an adjustment, the incidence rates 
mainly contain random errors that can be treated by 
standard  statistical  approaches.  In  the  calculations 
presented  below,  we  used  age-specific  incidence 
rates adjusted for time period and cohort effects.
generalized beta model
To fit the filtered observational data on age-specific 
incidence rates, we tested various models, such as: 
a  gamma  function,  a  Weibull  function,  a  special 
variant of the Beta function proposed by Harding and 
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By  setting  u1 = 1,  we  can  find  eight  unknowns, 
u2, u2, …, u9, from this system of eight Equations.
When the exact mathematical form of the hazard 
function  h(t)  is  unknown,  we  experience  the  well-
known “identifiable problem.” In this case, simultaneous 
evaluation of the time period and cohort effects can 
only  be  performed  using  additional  assumptions.8 
To solve this problem, we used an iterative technique 
proposed by Luebeck and Moolgavkar.15
Initially,  we  assumed  that  the  cohort  effect  was 
absent  (u = 1)  and  evaluated  coefficients  of  the 
coauthors,6 and the Generalized Beta (GB) probability 
distribution function defined as:
	 Ir(T	) = c(bT	)k-1 (1 - bT	)m-1  (7)
where T = (t - A), t is the age at cancer diagnosis; the 
incidence rate Ir	(T	) = I(t); b B A = - 1 ( );
A and B are the lower and upper age limits of cancer 
development,  respectively;  c  is  a  generalized  rate 
constant; k - 1 and m - 1 are the degrees of increase and 
decrease in cancer incidence rates, correspondingly.Mdzinarishvili et al
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Our results suggest that the best fit can be obtained 
by using the GB function presented by Equation 7. 
I(t) can be also presented as:
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For  each  age  interval,  j,  the  corresponding  age-
adjusted  incidence  rates,  I(tj),  and  their  standard 
errors (SEj), can be obtained from the SEER data; and 
the coefficient of variance, CV, can be determined 
as: CV SE I t j j j = ( ).  
For  each  age  interval,  the  SEER  data  presents 
the incidence rates as well as the number of cases, 
which can be considered as a Poisson distribution.10,14 
For large case numbers, the incidence rates can be 
viewed as variables that are approximately normally 
distributed around expected I(tj) with standard error 
SEj. To calculate incidence rates, we considered only 
those age intervals that contain at least five cases; 
otherwise we assumed that in the corresponding age 
interval the value of the incidence rate was 0.
Values  of  the  A  and  B  age  limits  of  cancer 
development can be considered as known a	priori. 
Traditionally,  the  lower  age  limit  A  has  been 
chosen  as  0,  assuming  that  the  process  of  cancer 
development  starts  from  the  birth.3 The  upper  age 
limit,  B,  can  be  treated  as  an  approximation  of 
the upper limit of the life span, or the age at which 
the  best  curve-fitting  is  obtained.5,6  It  should  be 
noted that the model variables c,	k and m are very 
sensitive  to  variations  of  the  A  and  B  age  limits. 
In this case, the problem of the curve-fitting becomes 
a so-called “ill posed” problem. Therefore, the use 
of a	priori information is necessary to stabilize the 
solution against variations of the input parameters, 
A and B.16 In this work, for simplicity, we fixed the 
age interval of cancer development as: A = 0 year and 
B = 100 years.
Thus, for each age interval, i, one can calculate 
Ti = (ti - A) and obtain Ir	 (Ti	 	 	) = I(tj) and their standard 
errors SE[Ir(Ti)] = SEi. Taking logarithms from both 
sides  of  Equation  7  in  each  age  interval,  one  can 
obtain a system of linear Equations:
ln Ir(Ti) = ln c + (k	- 1) ln bTi  
  + (m - 1) ln(1 - bTi), i = 1, 2, …, n.  (9)
Where  n  is  the  number  of  the  considered  age 
intervals.
Table 2. Presentation of the observed incidence rates as the product of the hazard function, h(t), and the corresponding 
time period (v) and birth cohort (u) coefficients.
period of observation
Age group 1985–89 1990–94 1995–99 2000–04 Birth cohort
Index, i Mid point, ti j = 1 j = 2 j = 3 j = 4 Index, l Years
1 2.5
⋅⋅⋅ ⋅⋅⋅
7 32.5 v1u9 h(t7)
8 37.5 v1u8 h(t8) v2u9 h(t8)
9 42.5 v1u7 h(t9) v2u8 h(t9) v3u9 h(t9)
10 47.5 v1u6 h(t10) v2u7 h(t10) v3u8 h(t10) v4u9 h(t10) 9 1955–59
11 52.5 v1u5 h(t11) v2u6 h(t11) v3u7 h(t11) v4u8 h(t11) 8 1950–54
12 57.5 v1u4 h(t12) v2u5 h(t12) v3u6 h(t12) v4u7 h(t12) 7 1945–49
13 62.5 v1u3 h(t13) v2u4 h(t13) v3u5 h(t13) v4u6 h(t13) 6 1940–44
14 67.5 v1u2 h(t14) v2u3 h(t14) v3u4 h(t14) v4u5 h(t14) 5 1935–39
15 72.5 v1u1 h(t15) v2u2 h(t15) v3u3 h(t15) v4u4 h(t15) 4 1930–34
16 77.5 v2u1 h(t16) v3u2 h(t16) v4u3 h(t16) 3 1925–29
17 82.5 v3u1 h(t17) v4u2 h(t17) 2 1920–24
18 87.5+ v4u1 h(t18) 1 1915–19Modeling of cancer incidence rates in aging
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According to Equation 8, the system (Equation 9) 
can be rewritten as:
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Three  unknown  parameters,  ln  c,  (k - 1)  and 
(m - 1), can be determined from Equation 9 or 10 
by  minimizing  the  following  function  R*  using  a 
weighted least square method:
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where wi is a weight of the i-th residual, (Oi - Ci), 
which is the deviation between the observed value, 
Oi, of the ln [Ir(Ti)] and its expected value calculated 
by Equation 9 in the following way:
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Based on the rules of the error propagation,17 one 
can show that the variance of errors for ln [Ir(Ti)] is 
approximately equal to the square of the coefficient 
of a variation of the incidence rate: CV SE I t i i i
2 2
= ( ) ( ) . 
It also can be shown that, when  w CV i i = ( ) 1 ,
2
 the 
weighted sum of residuals
 
R R w O C i
i
n
i i
* * ( ) ν = = -
= ∑
1
2   (13)
has  a  χν
2  distribution  with  ν = n – p  degrees  of 
freedom,  and  p = 3  is  the  number  of  derived 
parameters.18
By numerical experiments, we have shown that 
for small variances of error in incidence rate data, 
the  distribution  of  errors  of  ln Ir	(Ti)  is  close  to 
normal.  On  the  other  hand,  systems  like  systems 
(Equations 9 and 10) with normally distributed errors 
in the dependent variable, can be solved by multiple 
linear regression analysis.19 Therefore, in this work 
we used the multiple linear regression analysis to solve 
the system (Equation 10). To estimate the goodness 
of model fitting, we used a standard χ2 test.19
Results and Discussion
Comparison of distributions of the raw 
and filtered age-specific incidence rates 
for PC and KC
As described in Materials	and	Methods, we extracted 
the raw and filtered age-specific incidence rates for 
PC and KC for white males and females collected in 
the SEER 9 database during the years of 1985–2004 
and combined these data in four time period subsets: 
1985–1989, 1990–1994, 1995–1999, and 2000–2004. 
The age distributions of the raw and filtered data, 
gathered  in  each  of  these  subsets,  are  shown  in 
Figure 1. As can be seen from this figure, the age 
patterns corresponding to the raw and filtered incidence 
rates for the same type of cancer have significantly 
different amplitudes and shapes. The large differences 
in amplitudes are caused by the inclusion of cases 
of non-first primary and metastatic cancer, as well 
as cases with microscopically unconfirmed tumors 
in the raw data. The number of cases excluded by 
these criteria are detailed in Table 3. In addition, the 
age patterns of the filtered incidence rates exhibit the 
existence of a decline at old ages, while in the cases 
of unfiltered data this fall is not evident. The obvious 
deceleration/decline that the filtered incidence rates 
exhibit at age 75 and over cannot be caused just by 
a diagnostic bias at old ages, but rather it strongly 
suggests an influence of basic biological processes 
on  carcinogenesis  and  the  rates  of  clinical  cancer 
manifestation at an old age.20 Because it is clear that 
the filtered incidence rates represent more reliable 
and more homogeneous statistical data than the raw 
data, in the present work we exclusively used the 
filtered data.
Figures  2  and  3  show  how  time  period  and 
cohort  adjustments  affect  the  overall  shape  of  age 
distributions  of  PC  and  KC  for  white  males  and 
females.  Because  all  adjustments  were  made  by 
using  data  schematically  shown  in  Table  2,  these 
figures presented the age distributions of nine cohorts 
(1915–1919;  1920–1924;  1925–1929;  1930–1934; 
1935–1939; 1940–1944; 1945–1949; 1950–1954; and 
1955–1959)  during  four  time  periods  (1985–1989; 
1990–1994; 1995–1999; and 2000–2004). Therefore, 
during the first considered time period, 1985–1989, 
these  nine  cohorts  exhibit  incidence  rates  in  the 
following nine five-year age intervals: 30–34; 35–39; Mdzinarishvili et al
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40–44;  45–49;  50–54;  55–59;  60–65;  65–69;  and 
70–74.  During  the  next  considered  time  periods, 
these nine cohorts exhibit incidence rates in the nine 
five-year age intervals shifted by five years compared 
to the previous time period.
Thus, for the 30–34 age interval, only one observation 
made in the first time period, 1980–1984, was used. 
For the 35–39 age interval, two observations made 
in the first and second time periods, 1980–1984 and 
1985–89, correspondingly, were used. Analogously, 
three observations for the age interval 40–44 made in 
the first three time periods and four observations for 
each of the 50–54, 55–59, 60–64, 65–69 and 70–74 
age intervals, made during all considered time periods 
were utilized. In the cases of the 75–79, 80–84, and 
85+ age intervals, three, two and one observations 
were used as shown in Table 2.
Figures  2  and  3  show  influence  of  adjustments 
on  PC  and  KC  incidence  rates,  correspondingly. 
Below, we demonstrate that the age distributions of 
the adjusted incidence rates for PC and KC can be 
very well approximated using the generalized Beta 
function defined by Equation 7.
Mathematical models of age distribution 
of PC and KC
To estimate the model parameters in Equation 8, we 
minimized the weighted sum R* (Equation 11) by 
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Figure 1. Age-specific incidence rates of PC and KC obtained from the raw and filtered SEER data. (A) PC in white males; (B) PC in white females; 
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a least squares method. To do this, we utilized the 
regress function of the MATLAB software package.21 
For this function, we used n = 35 values of the adjusted 
incidence rates Iij(ti), and their SEi as input data. The 
rate for the 85 + age interval was not used due to an 
uncertainty of its middle point position. This resulted 
in  three  estimated  model  parameters,  c,  k,  and  m, 
and their 95% confidence intervals (CI), assuming 
that  A = 0  and  B = 100.  The  obtained  parameters 
are supposed to determine the best curve fitting that 
system (Equation 10) can provide for the adjusted 
incidence rates that were used as input data.
We  examined  the  goodness  of  the  curve  fit 
by the χ   2 test for the values of the weighted sum 
of  residuals  R*ν  (Equation  13).  The  degrees  of 
freedom, ν = n – p, was defined by the number of 
used data points (n	= 35), less the number of derived 
parameters  ( p	= 3).  According  to  the  standard 
χ  2 test with the 0.05 significance level, if the value 
of R*ν was outside the interval ( χ   2
0.025,ν; χ   2
0.975,ν), 
we  would  reject  the  hypothesis  that  our  model 
fits the observed data. The two tail limit values of 
the χ   2 test were χ   2
0.025,32 = 18.3 and χ   2
0.975,32 = 49.5, 
correspondingly.  Therefore,  in  the  case  when 
the weighted sum of residuals, R*ν  , is within the 
interval 18.3  R*ν  49.5, one can conclude that 
the  null  hypothesis  (that  the  distribution  of  the 
modeled incidence rates obtained by Equation 10 
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Figure 2. Age-specific incidence rates for PC in white males and females obtained from the filtered SEER data. (A) Unadjusted for time period 
and cohort effects incidence rates for white males; (B) adjusted for time period and cohort effects incidence rates for white males; (c) unadjusted for time 
period and cohort effects incidence rates for white females; (D) adjusted for time period and cohort effects incidence rates for white females.
notes: Time periods of data presented in panel A are shown in the legend. Time periods presented in panels B, c and D are the same as in panel A.Modeling of cancer incidence rates in aging
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fits the set of adjusted values) is not rejected at the 
0.05 significance level.
Table  4  presents  the  obtained  values  of  model 
parameters and descriptive statistics. Figure 4 shows 
the results of modeling of the age-specific incidence 
rates of PC and KC for the white male and female 
populations.  As  was  mentioned  previously,  the 
incidence rates for the age interval 85+ were not used 
as input data for the curve fitting. These incidence 
rates  are  shown  on  Figure  4  only  for  illustration 
purposes. Figure 4 shows that the modeled incidence 
rates  well  approximate  the  adjusted  values  of  the 
observed incidence rates (including the 85+ point). 
This good visual fit is strongly supported by the χ2 
tests, which suggest that in all cases the values of the 
weighted sum of residuals, R* ν   , are within the given 
interval, 18.3  R*ν  49.5 (see Table 4).
In Table 4 the parameters k and m assess the degrees 
of the increase and decrease in cancer incidence rate, 
correspondingly.  The  parameter  c  is  related  to  an 
overall risk of getting a cancer for a given population. 
The point of inflection indicates the point in which 
the second derivative of I(t) (Equation 7) is equal 
to  0,  which  corresponds  to  the  age  at  which  the 
decrease begins to prevail over the increase in cancer 
incidence rate. We did not consider the second point 
of inflection due to uncertainties of data at very old 
ages. The maximum indicates the age at which the 
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Figure 3. Age-specific incidence rates for KC in white males and females obtained from the filtered SEER data. (A) Unadjusted for time period 
and cohort effects incidence rates for white males; (B) adjusted for time period and cohort effects incidence rates for white males; (c) unadjusted for time 
period and cohort effects incidence rates for white females; (D) adjusted for time period and cohort effects incidence rates for white females.
notes: Time periods of data presented in panel A are shown in the legend. Time periods presented in panels B, c and D are the same as in panel A.Mdzinarishvili et al
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Table 4. Descriptive statistics and model parameters for pancreatic and kidney cancer. 
pancreatic cancer Kidney cancer
  Male Female Male Female
number of cancer cases (n) 13,919 13,306 20,054 12,106
Parameter c × 10,000† 2.9 (2.1, 4.1) 1.5 (1.0, 2.4) 2.5 (1.9, 3.3) 0.3 (0.2, 0.5)
Parameter k† 10.2 (9.8, 10.5) 10.2 (9.8, 10.7) 8.9 (8.6, 9.1) 7.8 (7.4, 8.2)
Parameter m† 3.7 (3.6, 3.9) 3.4 (3.2, 3.6) 3.9 (3.8, 4.0) 3.2 (2.9, 3.4)
Weighted sum of residuals (R*ν     ) 25.0 39.0 24.5 46.0
Point (age) of inflection 64.3 66.7 58.6 60.6
Age of maximum incidence 77.0 79.1 72.8 75.7
†Numbers in parentheses denote 95% confidence intervals.
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Figure 4. The GB approximation of the age-specific incidence rates adjusted for time period and cohort effects. (A) PC in white males; (B) PC in 
white females; (c) KC in white males; (D) KC in white females.
note: error bars denote standard errors (se).Modeling of cancer incidence rates in aging
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incidence rate reaches its maximum, after which the 
cancer incidence rate declines.
Table 4 and Figures 4A and 4B suggest that the 
parameter c for PC in white males is higher than for 
white  females.  However,  the  confidence  intervals 
of this parameter for males and females are slightly 
overlapping. For PC, the values of the parameter k in 
males and females are statistically indistinguishable, 
while  the  values  of  parameter  m  for  males  are 
statistically  higher  than  for  females.  The  higher 
value of m in males is a result of the point (age) of 
inflection and maximum incidence rate, which occur 
about  two  years  earlier  in  males  than  in  females. 
This may suggest that biological mechanisms of PC 
development differ in white males and females.
As can be seen from Table 4 and Figures 4C and 4D, 
in the case of KC all three model parameters, c, k, 
and m, for white males are statistically higher than 
those for white females. The point of inflection for 
males appears two years earlier than that for females, 
while  the  maximum  of  cancer  incidence  rate  for 
males appears about three years earlier than that for 
females. Notable differences in all parameters that 
characterize the age distributions of KC in males and 
females may suggest distinct biological mechanisms 
of KC development in white males and females.
A comparative analysis of the age patterns of the 
PC and KC incidence rates (see Table 4) suggests that 
for these types of cancer, the value of parameter m is 
greater than 2. This is in contrast to the assumption 
made  by  Harding  and  coauthors,6  where  it  was 
postulated  that  for  all  types  of  cancers,  m  should 
be equal to 2. As for parameter k, for PC in males 
and females the values of k are statistically higher 
than the ones for KC, which resulted in an earlier 
presentation of inflection points for KC incidence rates 
than for the PC (see Table 4). Analogous comparisons 
show that the peaks of the KC incidence rates appear 
four  years  earlier  than  the  corresponding  ones  of 
the  PC.  These  comparisons  suggest  the  existence 
of distinct organ-specific biological mechanisms of 
the carcinogenesis in the pancreas and kidney.
Goodness of curve fitting  
for different model functions
Among existing models,2,3,5,6,11,15 only special types 
of  the  Beta  function  as  proposed  by  Pompei  and 
Wilson,5 and Harding and coauthors,6 have an ability 
to describe the turnover of incidence rates at old age 
(for other models, incidence rates are monotonically 
increasing).  There  are  other  well-known  statistical 
models, such as the Gamma and Weibull functions, 
which, in principle, can also be used to describe this 
turnover. Therefore, using the weighted least squares 
method,  we  compared  the  goodness-of-fit  of  our 
proposed  GB  function  with  the  goodness-of-fit  of 
the special type of the Beta function (PW model), as 
well as the Gamma and Weibull functions. Figure 5A 
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Figure 5. Comparison of goodness-of-fit of the KC incidence rates in white males performed by the GB model (solid line) and other models. (A) The gB 
model vs. the PW model (dotted line). (B) The gB model vs. models described by the gamma (dotted line) and Weibull (dashed line) functions.
note: error bars denote standard errors (se).Mdzinarishvili et al
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shows the comparison of fitting of observational KC 
data for white males using the GB model versus the 
PW model. Figure 5B shows an analogous comparison 
of the GB, Gamma, and Weibull functions.
As can be seen from Figure 5, the GB model fits 
the pattern of the KC incidence rates in white males 
much better than the other considered models, and 
this visual appearance is well supported by the use 
of χ        2 statistic. In fact, the data from Table 4 show that 
the observed incidence rates of KC in white males 
can be very well fitted by the GB model. However, 
for  the  PW  model  and  the  Gamma  and  Weibull 
functions, the standard χ      2 test rejects the hypotheses 
that the curves described by these functions fit the 
observed data with the 0.05 significance level. In fact, 
for the PW model, the value of this statistic is equal 
to  565.0  with  ν = 32  degrees  of  freedom  (where 
ν = n - p, n	= 35 – the number of used data points, 
and p	= 3 - the number of parameters to be derived). 
Analogously,  for  the  Gamma  function  (ν = 33, 
two estimated parameters) this statistic is equal to 
1,720.6, and for the Weibull function this statistic is 
equal to 208.0 (ν = 33, two estimated parameters). For 
the special type of Beta function, the limit values of 
the χ  2 test are χ  2
0.025,32 = 18.3 and χ  2
0.975,32 = 49.5, and 
for the Gamma and Weibull functions, these values 
are χ  2
0.025,33 = 19.0 and χ  2
0.975,33 = 50.7. For all of these 
functions the values of the χ  2 statistic are outside of 
the defined intervals of the χ  2 test. Analogous results 
were obtained for KC incidence rates in white females, 
as well as for PC incidence rates in both white males 
and white females (data not shown). Therefore, these 
results clearly show that the GB model has superior 
performance compared to the other considered models.
conclusion
In  this  work,  we  emphasized  several  general 
shortcomings in the mathematical modeling of age 
distribution  of  cancer,  which  include:  the  use  of 
“raw” cancer data (inclusion of cases which were not 
microscopically confirmed or were not first primary 
cancers); the lack of consideration of time period and 
cohort effects on the observed incidence rates; and 
the omission of rigorous statistical evaluation of the 
determined  model  parameters.  To  overcome  these 
shortcomings, we proposed a new approach, called 
the Generalized Beta (GB) model. This model utilizes 
observational  data  of  age-specific  incidence  rates 
and  uses  sound  statistical  criteria  to  assess  model 
parameters.
To test the performance of this model, we used 
“filtered”  data  from  the  SEER  9  database  during 
the years of 1985–2004. We utilized these data to 
estimate  the  incidence  rates  of  the  first  primary, 
microscopically confirmed cases of pancreatic cancer 
(PC)  and  kidney  cancer  (KC)  in  white  males  and 
females. These incidence rates were adjusted for time 
period and cohort effects. By the newly proposed GB 
approach,  we  approximated  the  adjusted  incidence 
rates of the primary PC and KC in white males and 
females. Confidence intervals for model parameters 
were estimated by regression analysis. We showed 
that the age distributions of the KC and PC incidence 
rates have turnover points within the age interval of 
74–81,  after  which  these  distributions  fall  off  and 
reach the value of 0 (near the age of 100 years) at the 
end of the human life span.
The results presented in this work suggest that our 
approach  significantly  expands  the  possibilities  of 
modeling of age distributions in PC and KC. We are 
certain that this approach could be generalized for 
many  other  organ-specific  cancers  and  cancer 
subtypes  and  provide  distinct  model  parameters 
that will be useful for the modeling of carcinogenic 
processes characteristic to particular cancers. It should 
be  noted  that  in  this  work,  we  used  the  terms 
degree	of	increase or degree	of	decrease in a purely 
mathematical sense, because the precise mechanisms 
causing the increase and decrease of cancer incidence 
rates are not fully understood. To better understand 
the biological plausibility of the model parameters 
used in the proposed approach, detailed molecular, 
cellular  and  tissue-specific  mechanisms  underlying 
the development of each type of cancer will require 
further investigation. The model parameters that can 
be assessed by the proposed approach should challenge 
future biomedical and epidemiological studies.
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